Additional file 2: of Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial GordonJessica MartyanovViktor MagroCynthia WildmanHoratio WoodTammara HuangWei-Ti CrowMary WhitfieldMichael SpieraRobert 2015 Dermatopathology results. αSMA alpha smooth muscle actin, Egr early growth response protein. (DOCX 15 kb)